Based
PORTLAND, OREGON
PORTLAND, OREGON
Year formed
2021
2021
Industry group
Biotechnology
Biotechnology
Filings
5
5
Raised (new offerings)
$2.92M
$2.92M
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-11-17 | Amendment first sale 2025-10-06 | $3.38M | $3.50M | SEC filing |
| 2025-10-20 | New offering first sale 2025-10-06 | $2.92M | $3M | SEC filing |
| 2025-03-14 | Filing | — | — | SEC filing |
| 2024-09-09 | Amendment | — | — | SEC filing |
| 2023-09-13 | Filing | — | — | SEC filing |
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Pacific Diabetes Technologies, Inc.'s own filings with the SEC. The people those filings name are on the team page.